Contract Research Agreement signed with Nicoya to transfer, develop and evaluate a SubB2M-based Surface Plasmon Resonance (SPR) test on the Alto™ Digital SPR instrument Nicoya has commercialised Alto, a next-generation benchtop SPR instrument for the highly sensitive detection of analytes such as proteins, antibodies, nucleic acids and sugars Nicoya’s Alto has the potential to deliver […]

SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that Ascendas Genomics has received approval from the National Medical Products Administration (NMPA) of China for use of the company’s Biomark™ family of systems and its Juno™ system in NMPA molecular diagnostics services, enabling […]

Collaboration to unify NanoString’s best-in-class spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated end-to-end workflows for translational research studies. SEATTLE —  NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Visiopharm, a world leader in AI-driven digital pathology software, today announced a […]

BOSTON, Mass. – TetraScience, the Scientific Data Cloud company, announced today that DeepLife, a next-generation systems biology company, has joined the Tetra Partner Network to scale multi-omic workflows and accelerate AI-driven drug discovery through the Tetra Scientific Data Cloud™. “We applaud DeepLife’s powerful solutions for multi-omic research,” said Simon Meffan-Main, Ph.D., VP, Tetra Partner Network. […]

The partnership brings researchers a streamlined solution for multiplex tissue analysis that harnesses the Ultivue multiplex immuno-labeling strategy with the ZEISS platform for automated whole slide imaging and analysis. WHITE PLAINS, N.Y. and CAMBRIDGE, Mass. — Carl Zeiss Microscopy, LLC, today announced that it has entered into an agreement with Ultivue Inc. to co-market Ultivue’s multiplex biomarker assays […]

REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demonstrating the value of at-line cell culture media analysis to inform feeding […]

REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% BOSTON — 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demonstrating the value of at-line cell culture media analysis to inform feeding […]

State College, PA – Gamma Biosciences, a leading provider of tools and technologies for cell and gene therapy manufacturing, through their BioMagnetic Solutions business, today announced a strategic collaboration with Lonza. Under the multi-year agreement, BioMagnetic Solutions will supply its proprietary research and cGMP manufacturing grade FerroSelect™ reagents to Lonza for use in developing CAR-T and other […]

ONI’s Super-resolution Nanoimager will be used to identify predictive CAR-T biomarkers and characteristics related to treatment outcomes San Diego, CA and Oxford, UK – ONI, a single-molecule imaging platform biotech, today announced a research collaboration with the University of Pennsylvania, one of the true pioneers of CAR-T (chimeric antigen t-cell) research and clinical trials. The collaboration […]

Aims to improve efficiency of pharma pipelines by leveraging industry-leading ability to identify genetic variants that contribute to human disease SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by […]